$TPIVD shareholders will benefit from any positive clinical trial data as well as any (1)new partnerships with Big Pharma (2) the US gov't (military grants) (3) Clinics grants such as Mayo, MSK etc.
Shareholders continue to be patience as MFI(14) increasing now at 47.9 this morning.
As well IMO expecting PR, any day now, from $TPIVD mgmt regarding the NASDAQ uplisting date.
Market Data 
Markets 
AI
